phenylmethylsulfonyl fluoride has been researched along with am 404 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fowler, CJ; Lambert, DM | 1 |
| Adler-Graschinsky, E; Mendizábal, VE; Orliac, ML | 1 |
| Boachie-Ansah, G; Grainger, J | 1 |
| Coyne, L; David, LS; Errington, AC; Lees, G; Liao, C; Nicholson, RA; Singh, G; Zheng, J | 1 |
1 review(s) available for phenylmethylsulfonyl fluoride and am 404
| Article | Year |
|---|---|
The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications.
Topics: Amides; Amidohydrolases; Amines; Animals; Arachidonic Acids; Binding Sites; Cannabinoid Receptor Modulators; Drug Design; Endocannabinoids; Esters; Ethers; Glycerides; Humans; Ligands; Monoacylglycerol Lipases; Polyunsaturated Alkamides; Receptors, Cannabinoid | 2005 |
3 other study(ies) available for phenylmethylsulfonyl fluoride and am 404
| Article | Year |
|---|---|
Long-term inhibition of nitric oxide synthase potentiates effects of anandamide in the rat mesenteric bed.
Topics: Animals; Arachidonic Acids; Cannabinoid Receptor Modulators; Capsaicin; Dose-Response Relationship, Drug; Drug Synergism; Endocannabinoids; Enzyme Inhibitors; Guanylate Cyclase; In Vitro Techniques; Indoles; Male; Mesenteric Arteries; Morpholines; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Norepinephrine; Oxadiazoles; Phenylmethylsulfonyl Fluoride; Polyunsaturated Alkamides; Pyrazoles; Quinoxalines; Rats; Rats, Wistar; Time Factors; Vasoconstriction; Vasoconstrictor Agents | 2001 |
Anandamide-induced relaxation of sheep coronary arteries: the role of the vascular endothelium, arachidonic acid metabolites and potassium channels.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 4-Aminopyridine; Animals; Apamin; Arachidonic Acid; Arachidonic Acids; Barium; Calcium Channel Blockers; Cannabinoid Receptor Modulators; Cannabinoids; Capsaicin; Coronary Vessels; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Endocannabinoids; Endothelium, Vascular; Enzyme Inhibitors; Fatty Acids, Unsaturated; Glyburide; In Vitro Techniques; Indomethacin; Miconazole; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Peptides; Phenylmethylsulfonyl Fluoride; Piperidines; Polyunsaturated Alkamides; Potassium; Potassium Channel Blockers; Potassium Channels; Pyrazoles; Receptors, Drug; Rimonabant; Sheep; Tetraethylammonium; Vasoconstrictor Agents; Vasodilation | 2001 |
Sodium channel inhibition by anandamide and synthetic cannabimimetics in brain.
Topics: Analysis of Variance; Animals; Animals, Newborn; Arachidonic Acids; Batrachotoxins; Benzoxazines; Binding Sites; Brain; Calcium Channel Blockers; Cannabinoid Receptor Modulators; Cannabinoids; Cells, Cultured; Dose-Response Relationship, Drug; Drug Interactions; Endocannabinoids; Enzyme Inhibitors; gamma-Aminobutyric Acid; Glutamic Acid; Hydrocarbons, Fluorinated; In Vitro Techniques; Male; Membrane Potentials; Mice; Morpholines; Naphthalenes; Neurons; Neurotoxins; Patch-Clamp Techniques; Phenylmethylsulfonyl Fluoride; Polyunsaturated Alkamides; Potassium Chloride; Sodium Channel Agonists; Sodium Channel Blockers; Sodium Channels; Synaptosomes; Tetrodotoxin; Veratridine | 2003 |